drugset / Trial / NCT01104467

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke

NCT01104467 ↗

Phase 2 Completed 48 enrolled Lundbeck Japan K. K.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate whether desmoteplase is safe and tolerated when given to Japanese patients with acute ischemic stroke

Timeline

Start
2010-08
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmoteplase Protein / enzyme biologic 70 ug/kg Intravenous
Subject Desmoteplase Protein / enzyme biologic 90 ug/kg Intravenous

Indications